HALO: Nilai perusahaan marang bathi resik Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. - logo grafis emiten HALO

Insurmountable patent barriers and costly trials make entry into the drug delivery niche nearly impossible for Halozyme Therapeutics (HALO). The current P/E ratio visualizes this resilience, with the current value equal to 22.40. The business foundation is based on licensing technologies to pharma behemoths, while the royalty collection model ensures rapid profit growth with minimal operating expenses.

Koefisien rega marang bathi: Halozyme Therapeutics (HALO) kanggo 04.07.2022 - 17.11.2026

Rincian metrik komprehensif lan analitis Halozyme Therapeutics, Inc. (HALO)

- rega saham lan prakiraan rega para ahli:
Ringkesan analisis perusahaan:Halozyme - HALO
Barang unggulan Halozyme

The non-cyclical nature of Halozyme Therapeutics (HALO) biotech licensing guarantees a stable royalty stream regardless of macroeconomic shocks. The market capitalization-to-net income ratio mathematically reflects the value of this sustainable income. This coefficient measures investment efficiency and the impact of external factors on the issuer's real yield. The trend in the company's average P/E allows for an assessment of the market's recognition of the business and the timely identification of risks regarding overpaying for the asset.

Pesaing wigati

ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi RVMD (RevMed)|AAPG (Ascentage) - Nilai perusahaan marang bathi resik|Pangali P/E CGON (cgoncology.com)|URGN - Koefisien rega marang bathi|BCAX: Koefisien rega marang bathi|PSNL - Pangali P/E|Erasca Corp (ERAS) - Rasio rega marang bathi|Delcath - Nilai perusahaan marang bathi resik|YMAB (Y-mAbs Therapeutics Inc) - Pangali P/E|Kapitalisasi marang bathi Aura Biosciences, Inc. AURA|Pangali P/E CADL|Pangali P/E Accuray (ARAY)|Rasio rega marang bathi SELLAS Life Sciences Group Inc. SLS|ACTU - Koefisien rega marang bathi|CTOR: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Koefisien rega marang bathi|Kapitalisasi marang bathi Fate Therapeutics Corp (FATE)|Koefisien rega marang bathi WHWK|Pangali rega marang bathi TCRX (TScan Therapeutics, Inc.)|Pangali P/E CSBR|XBIT - Kapitalisasi marang bathi|CEL-SCI Corporation - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik OSTX|radiopharmtheranostics.com - Pangali P/E|ARTV: Rasio rega marang bathi|ANL (adlainortye.com) - Koefisien rega marang bathi|VERU - Periode bali modal bisnis|TPST (Tempest Therapeutics, Inc.) - Pangali P/E|Pangali P/E xiliotx.com|Rasio rega marang bathi Enochian BioSciences (RENB)|Rasio rega marang bathi MURA (Mural Oncology PLC)|Rasio rega marang bathi Kairos Pharma Ltd KAPA|Pangali P/E OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Pangali P/E|Periode bali modal bisnis Curis CRIS|APLM: Pangali P/E|Koefisien rega marang bathi Tharimmune, Inc.|ADVB (Advanced Biomed) - Pangali P/E|Genprex - Kapitalisasi marang bathi resik|Rasio rega marang bathi calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Nilai perusahaan marang bathi resik|Pangali P/E XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalisasi marang bathi|PPBT: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Rasio rega marang bathi|Checkpoint Therapeutics, Inc (CKPT) - Pangali P/E|Rasio rega marang bathi Elevation Oncology, Inc.|ICAD: Nilai perusahaan marang bathi resik|Rasio rega marang bathi ikenaoncology.com (IKNA)|Rasio rega marang bathi NTBL (Notable Labs, Ltd.)|Pangali P/E VIRX (viracta.com)|MOR - Koefisien rega marang bathi|NAYA - Rasio rega marang bathi|Kapitalisasi marang bathi resik AAPGV